M. Lenoci
Impact in
- Genetics top 5%
- Chronic Lymphocytic Leukemia Research
- Pathology and Forensic Medicine top 10%
- Lymphoma Diagnosis and Treatment
Papers in
-
- Lymphoma Diagnosis and Treatment 7
- Genetics 6
- Chronic Lymphocytic Leukemia Research 6
- Co-authors
- Francesco Lauria (7 shared papers)Monica Tozzi (4 shared papers)Donatella Raspadori (4 shared papers)Geraldo de Nardi (2 shared papers)Damiano Rondelli (2 shared papers)Giuseppe Marotta (4 shared papers)Caterina Mariotti (1 shared paper)Daniela Damiani (1 shared paper)
- Journals
- Leukemia (2 papers)British Journal of Haematology (2 papers)Journal of Clinical Microbiology (1 paper)Blood (1 paper)Leukemia & lymphoma (1 paper)
- Partner nations
- ItalyUnited KingdomSpain
In The Last Decade
M. Lenoci
10 papers receiving 352 citations
Peers
Comparison fields: 5 of 46
- Genetics 212
- Pathology and Forensic Medicine 190
- Hematology 110
- Immunology 131
- Oncology 76
Countries citing papers authored by M. Lenoci
This map shows the geographic impact of M. Lenoci's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Lenoci with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Lenoci more than expected).
Fields of papers citing papers by M. Lenoci
This network shows the impact of papers produced by M. Lenoci. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Lenoci. The network helps show where M. Lenoci may publish in the future.
Co-authors
The 25 scholars most cited alongside M. Lenoci, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2001 | 127 | |
| 2 | Efficacy of anti-CD20 monoclonal antibodies (Mabthera) in patients with progressed hairy cell leukemia. | 2001 | 68 |
| 3 | 2008 | 56 | |
| 4 | Low-dose fludarabine and cyclophosphamide in elderly patients with B-cell chronic lymphocytic leukemia refractory to conventional therapy. | 2000 | 41 |
| 5 | 2006 | 40 | |
| 6 | 1999 | 14 | |
| 7 | 2008 | 8 | |
| 8 | 2004 | 4 | |
| 9 | 2005 | 3 | |
| 10 | 2003 | 1 |
About M. Lenoci
M. Lenoci is a scholar working on Pathology and Forensic Medicine, Genetics, Oncology, Epidemiology and Radiology, Nuclear Medicine and Imaging, having authored 10 papers that have together received 362 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (7 papers), Chronic Lymphocytic Leukemia Research (6 papers), Immunodeficiency and Autoimmune Disorders (2 papers), Monoclonal and Polyclonal Antibodies Research (2 papers), Cytomegalovirus and herpesvirus research (1 paper), Breast Cancer Treatment Studies (1 paper), Antifungal resistance and susceptibility (1 paper) and Acute Myeloid Leukemia Research (1 paper). The work is most often cited by research in Genetics (212 citations), Pathology and Forensic Medicine (190 citations), Hematology (110 citations), Immunology (131 citations) and Oncology (76 citations). M. Lenoci has collaborated with scholars based in Italy, United Kingdom and Spain. Frequent co-authors include Francesco Lauria, Monica Tozzi, Donatella Raspadori, Geraldo de Nardi, Damiano Rondelli, Giuseppe Marotta, Caterina Mariotti, Daniela Damiani, Monica Bocchia and Nicoletta Testoni. Their work appears in journals such as Leukemia, British Journal of Haematology, Journal of Clinical Microbiology, Blood and Leukemia & lymphoma.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.